Benzocaine products recall in Canada: Methemoglobinemia risk for children
In plain language
This advisory involves over-the-counter benzocaine products sold in Canada. They are not recommended for children under two years of age due to the risk of methemoglobinemia, a serious blood condition. Parents and caregivers should not use these products in young children and should consult a healthcare professional for alternatives.
What to do
- Do not use benzocaine products in children under two years of age.
- Consult a healthcare professional for alternative pain relief options.
- Store all health products out of reach of children.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Methemoglobinemia risk for children under two years of age
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Methemoglobinemia risk for children under two years of age
What should consumers do?
Do not use benzocaine products in children under two years of age. Consult a healthcare professional for alternative pain relief options. Store all health products out of reach of children.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Methemoglobinemia risk for children under two years of age
When was this product recalled?
This product was recalled on October 15, 2020.